Medicine guide

CODEINE CONTIN

As listed in the register: CODEINE CONTIN 150MG CONTROLLED RELEASE TAB

150 mg · tablet (extended-release)

  • Prescription only
  • Breathing, airways, allergies and cough
Made by
Purdue Pharma

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBreathing, airways, allergies and coughR05DA04

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byPurdue Pharma
Active substanceCodeine (Codeine Sulfate Trihydrate, Codeine Monohydrate)
Used inBreathing, airways, allergies and cough
Strength150 mg
Formtablet (extended-release)
ClassificationR05DA04 · Breathing, airways, allergies and cough
Routeoral
Dispensing (as stated by the register)NARCOTICS (CDSA I)
StatusMarketed
MarketedYes, according to the register
Name in the registerCODEINE CONTIN 150MG CONTROLLED RELEASE TAB
DIN02163780
DPD drug code19051

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.